Latest Breaking News On - Tricuspid therapies - Page 1 : comparemela.com

Edwards Lifesciences Reports First Quarter Results

Edwards Lifesciences today reported financial results for the quarter ended March 31, 2024. Highlights and Outlook Q1 sales grew 10% on a reported and constant currency1 basis to $1.6.

United statesBernard zovighianEdwards lifesciencesDrug administrationProduct groupMedtronic incSecurities exchangeExchange commissionEdwards lifesciences corporationAortic valve replacementTricuspid therapiesStructural heartLatin americaEdward smart recoveryCritical careSurgical structural heart

Edwards Lifesciences Q1 Earnings: Mixed Results with Adjusted EPS Beating Estimates

Insights into Edwards Lifesciences' Financial Performance and Strategic Highlights

Bernard zovighianEdwards lifesciencesEdwards lifescienceEdwards lifesciences corpTranscatheter aortic valve replacementTranscatheter mitralTricuspid therapiesCritical careStructural heart diseaseTranscatheter aortic valve replacementRobust sales growth

Edwards Lifesciences: EVOQUE FDA Approval; Critical Care Spin-Off

Edwards Lifesciences: EVOQUE FDA Approval; Critical Care Spin-Off
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesEdwards lifesciencesTim rue corbisTranscatheter heart valve assemblyNational library of medicineHeart valveCorbis historicalStrong buyEdwards lifesciences quarterlyCritical careNational libraryTranscatheter mitralTricuspid therapiesTranscatheter aortic valve replacementBoston scientificEdwards lifescience

Edwards Lifesciences Reports Fourth Quarter Results

Edwards Lifesciences today reported financial results for the quarter ended December 31, 2023. Highlights and Outlook Q4 sales grew 14 percent to $1.53 billion; constant currency1 sales grew 13.

United statesEdwards lifesciencesBernard zovighianDrug administrationProgram discontinuationEdwards lifesciences corporationExchange commissionMedtronic incSecurities exchangeProduct groupAortic valve replacementTricuspid therapiesStructural heartSmart recoveryHypotension prediction indexSecurities act

Edwards to Spin Off $1B Critical Care Unit - Orange County Business Journal

A new medtech company with almost a billion dollars in sales is being formed in Irvine.Edwards Lifesciences Corp. (NYSE: EW) is planning next year to spin off its Critical Care unit, which makes a variety of patient monitoring products for hospital settings.

Dominican republicPuerto ricoKatie szymanMichael mussallemBernard zovighianCheetah medical incLidco groupIrvine masimo corpEdwards lifesciences corpBaxter internationalCritical careCare corporate vice president katie szymanOrange countyTranscatheter aortic valve replacementTranscatheter mitralTricuspid therapies